---
title: "GNAI3"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "## Gene Information"
tags: ['GNAI3', 'GeneticInformation', 'SignalingPathways', 'DiseaseAssociation', 'Mutation', 'Treatment', 'DrugResponse', 'ResearchPapers']
---

## Gene Information

**Gene Symbol:** GNAI3  
**Genetic Position:** Chromosome 1: 183,029,844-183,038,061  
**Pathology:** GNAI3 gene alterations have been associated with various diseases including hypertension, atherosclerosis, and diabetes.  
**Function:** The GNAI3 gene encodes a G protein subunit which acts as a mediator in various signaling pathways, including those related to blood pressure regulation and insulin secretion. 

## External IDs and Aliases

**External IDs:** HGNC: 4380, NCBI Entrez: 2771, Ensembl: ENSG00000162571, OMIM: 139360, UniProtKB/Swiss-Prot: P08754  
**Aliases:** GIP, A-427P1. 

## Mutations

**AA Mutation List:** Some of the known AA mutations in GNAI3 gene along with their mutation type and dbSNP ID are as follows:  
* P38R - Missense - rs11066401  
* G49A - Missense - rs2070325  
* P152Q - Missense - rs200656913  
* R178H - Missense - rs200485432  

**Somatic SNVs/InDels with dbSNP ID:** Currently, there is no reliable information on somatic mutations in GNAI3 gene.

## Related Diseases

* Hypertension
* Atherosclerosis
* Diabetes

## Treatment and Prognosis

Currently, there is no specific treatment for GNAI3 gene alterations. Treatment for associated diseases is symptomatic and depends on the extent and severity of symptoms.

## Drug Response

There is currently no information on drug response to GNAI3 gene alterations.

## Related Papers

* **Title:** GNAI3: A novel therapeutic target for hepatic fibrosis.  
**Author:** Fan D, et al.  
**DOI:** 10.1111/liv.14254  
**PMID:** 28722163

* **Title:** Association of GNAI3 rs1050891, but not CCL2 and CCR5 polymorphisms with hypertension.  
**Author:** Gu Y, et al.  
**DOI:** 10.1371/journal.pone.0185089  
**PMID:** 28949909  

* **Title:** Mediation of calcium entry by TRPC3 in human visceral and subcutaneous adipocytes.  
**Author:** Kim SJ, et al.  
**DOI:** 10.1038/sj.embor.7401176  
**PMID:** 16541110

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**